Tailoring Multi-omics to Inflammatory Bowel Diseases: All for One and One for All

被引:16
作者
Sudhakar, Padhmanand [1 ]
Alsoud, Dahham [1 ]
Wellens, Judith [1 ]
Verstockt, Sare [1 ]
Arnauts, Kaline [1 ]
Verstockt, Bram [1 ,2 ]
Vermeire, Severine [1 ,2 ]
机构
[1] Katholieke Univ Leuven, Dept Chron Dis Metab & Ageing, Translat Res Ctr Gastrointestinal Disorders TARGI, Leuven, Belgium
[2] Katholieke Univ Leuven, Univ Hosp Leuven, Dept Gastroenterol & Hepatol, Leuven, Belgium
基金
欧洲研究理事会;
关键词
IBD complexity; -omic datasets; sparsity; exposome; validation; strategies tailored to IBD; coordinated funding; collaborative research; GENOME-WIDE ASSOCIATION; CROHNS-DISEASE; GENETIC ARCHITECTURE; PREDICTS RESPONSE; SYSTEMS BIOLOGY; RISK-FACTORS; CANCER; THERAPY; EXPOSOME; MICROBIOME;
D O I
10.1093/ecco-jcc/jjac027
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Inflammatory bowel disease [IBD] has a multifactorial origin and originates from a complex interplay of environmental factors with the innate immune system at the intestinal epithelial interface in a genetically susceptible individual. All these factors make its aetiology intricate and largely unknown. Multi-omic datasets obtained from IBD patients are required to gain further insights into IBD biology. We here review the landscape of multi-omic data availability in IBD and identify barriers and gaps for future research. We also outline the various technical and non-technical factors that influence the utility and interpretability of multi-omic datasets and thereby the study design of any research project generating such datasets. Coordinated generation of multi-omic datasets and their systemic integration with clinical phenotypes and environmental exposures will not only enhance understanding of the fundamental mechanisms of IBD but also improve therapeutic strategies. Finally, we provide recommendations to enable and facilitate generation of multi-omic datasets.
引用
收藏
页码:1306 / 1320
页数:15
相关论文
共 127 条
[1]   Early life exposures and the risk of inflammatory bowel disease: Systematic review and meta-analyses [J].
Agrawal, Manasi ;
Sabino, Joao ;
Frias-Gomes, Catarina ;
Hillenbrand, Christen M. ;
Soudant, Celine ;
Axelrad, Jordan E. ;
Shah, Shailja C. ;
Ribeiro-Mourao, Francisco ;
Lambin, Thomas ;
Peter, Inga ;
Colombel, Jean-Frederic ;
Narula, Neeraj ;
Torres, Joana .
ECLINICALMEDICINE, 2021, 36
[2]   Novel and Emerging Therapies for Inflammatory Bowel Disease [J].
Al-Bawardy, Badr ;
Shivashankar, Raina ;
Proctor, Deborah D. .
FRONTIERS IN PHARMACOLOGY, 2021, 12
[3]   The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017 [J].
Alatab, Sudabeh ;
Sepanlou, Sadaf G. ;
Ikuta, Kevin ;
Vahedi, Homayoon ;
Bisignano, Catherine ;
Safiri, Saeid ;
Sadeghi, Anahita ;
Nixon, Molly R. ;
Abdoli, Amir ;
Abolhassani, Hassan ;
Alipour, Vahid ;
Almadi, Majid A. H. ;
Almasi-Hashiani, Amir ;
Anushiravani, Amir ;
Arabloo, Jalal ;
Atique, Suleman ;
Awasthi, Ashish ;
Badawi, Alaa ;
Baig, Atif A. A. ;
Bhala, Neeraj ;
Bijani, Ali ;
Biondi, Antonio ;
Borzi, Antonio M. ;
Burke, Kristin E. ;
Carvalho, Felix ;
Daryani, Ahmad ;
Dubey, Manisha ;
Eftekhari, Aziz ;
Fernandes, Eduarda ;
Fernandes, Joao C. ;
Fischer, Florian ;
Haj-Mirzaian, Arvin ;
Haj-Mirzaian, Arya ;
Hasanzadeh, Amir ;
Hashemian, Maryam ;
Hay, Simon, I ;
Hoang, Chi L. ;
Househ, Mowafa ;
Ilesanmi, Olayinka S. ;
Balalami, Nader Jafari ;
James, Spencer L. ;
Kengne, Andre P. ;
Malekzadeh, Masoud M. ;
Merat, Shahin ;
Meretoja, Tuomo J. ;
Mestrovic, Tomislav ;
Mirrakhimov, Erkin M. ;
Mirzaei, Hamed ;
Mohammad, Karzan A. ;
Mokdad, Ali H. .
LANCET GASTROENTEROLOGY & HEPATOLOGY, 2020, 5 (01) :17-30
[4]   Food and the gut microbiota in inflammatory bowel diseases: a critical connection [J].
Albenberg, Lindsey G. ;
Lewis, James D. ;
Wu, Gary D. .
CURRENT OPINION IN GASTROENTEROLOGY, 2012, 28 (04) :314-320
[5]   Breaking the therapeutic ceiling in drug development in ulcerative colitis [J].
Alsoud, Dahham ;
Verstockt, Bram ;
Fiocchi, Claudio ;
Vermeire, Severine .
LANCET GASTROENTEROLOGY & HEPATOLOGY, 2021, 6 (07) :S89-S95
[6]   Gut Microbiome Function Predicts Response to Anti-integrin Biologic Therapy in Inflammatory Bowel Diseases [J].
Ananthakrishnan, Ashwin N. ;
Luo, Chengwei ;
Yajnik, Vijay ;
Khalili, Hamed ;
Garber, John J. ;
Stevens, Betsy W. ;
Cleland, Thomas ;
Xavier, Ramnik J. .
CELL HOST & MICROBE, 2017, 21 (05) :603-+
[7]   Epidemiology and risk factors for IBD [J].
Ananthakrishnan, Ashwin N. .
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2015, 12 (04) :205-217
[8]   Mucosal gene signatures to predict response to infliximab in patients with ulcerative colitis [J].
Arijs, I. ;
Li, K. ;
Toedter, G. ;
Quintens, R. ;
Van Lommel, L. ;
Van Steen, K. ;
Leemans, P. ;
De Hertogh, G. ;
Lemaire, K. ;
Ferrante, M. ;
Schnitzler, F. ;
Thorrez, L. ;
Ma, K. ;
Song, X. -Y R. ;
Marano, C. ;
Van Assche, G. ;
Vermeire, S. ;
Geboes, K. ;
Schuit, F. ;
Baribaud, F. ;
Rutgeerts, P. .
GUT, 2009, 58 (12) :1612-1619
[9]   Genetic Markers Predict Primary Non-Response and Durable Response To Anti-TNF Biologic Therapies in Crohn's Disease [J].
Barber, Grant E. ;
Yajnik, Vijay ;
Khalili, Hamed ;
Giallourakis, Cosmas ;
Garber, John ;
Xavier, Ramnik ;
Ananthakrishnan, Ashwin N. .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2016, 111 (12) :1816-1822
[10]   Gene-Disease Network Analysis Reveals Functional Modules in Mendelian, Complex and Environmental Diseases [J].
Bauer-Mehren, Anna ;
Bundschus, Markus ;
Rautschka, Michael ;
Mayer, Miguel A. ;
Sanz, Ferran ;
Furlong, Laura I. .
PLOS ONE, 2011, 6 (06)